Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InFLOW: Inhaled Fluticasone Effects on Upper Airway Patency
NCT01554488Phase 4Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Mar 2013
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate nasal spray in asthma, chronic obstructive pulmonary disease (COPD), sponsored by VA Office of Research & Development. Started Mar 2013; status: terminated.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01554488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01554488.